PET scan with FAPI tracer for cancer imaging
Part of Cancer clinical trials.
This study uses a special PET scan called 18F-FAPI-04 to take detailed images of different kinds of cancer. It aims to see if this scan can help doctors better find and monitor tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a known or suspected cancerous tumor, or be starting or continuing treatment for cancer.
- You must not have a non-cancerous tumor (benign lesion).
- You cannot be pregnant.
- You (or your parent or legal guardian) must be able to sign a consent form agreeing to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a new type of PET scan (called FAPI) to better see if cancer has spread to lymph nodes or other parts of the body. It may help your doctor plan the right treatment without needing invasive tests.
This study compares two types of PET scans (FDG and FAPI) in people with suspected or newly diagnosed cancer. It aims to learn which scan gives better images of different cancers, potentially helping guide treatment decisions.
This study uses a new imaging agent called [68Ga]-FAPI-JNU to take detailed pictures of tumors with a PET/CT scan. It aims to see how well this tracer works in people with various types of cancer.
This study compares two special PET/CT scan tracers—68Ga-FAPI-LM3 and 18F-FDG—to see how well they detect cancer that shows FAP or SSTR2 signals. It may help doctors choose better imaging to find or assess certain tumors.
This trial studies a special PET/CT scan called FAPI PET/CT to see how well it can detect or track cancerous tumors. It may help doctors better understand your cancer without extra procedures.
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.